EMA
approval
· 2020-06-26
New medicine for cystic fibrosis patients
Summary
EMA announces a new medicine for cystic fibrosis patients, signaling an important approval or landmark development for CF treatment in Europe.
Upgrade for the full analysis, importance score, and drug timeline.